Everything seems to be lining up nicely. However I would say the 'significant de-risking' occurs when positive IV trials come in. Not to say the burn trial updaters aren't encouraging. But with positive IV results we should expect some big eyes on us. GL to all.
Ann: Patients to be Dosed in Ph 1 IV Clinical Trial of R327, page-7
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.5¢ |
Change
0.005(1.06%) |
Mkt cap ! $96.89M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 47.5¢ | 47.0¢ | $134.2K | 284.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 60696 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.5¢ | 13798 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |